The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...
Research and development (R&D) of Structural Heart products, chiefly DurAVR THV (Transcatheter Heart Valve) for the treatment of aortic stenosis and its ComASUR delivery system which allows accurate ...
Execution of Vittangi Anode Project development including advancing offtake negotiations to allocate Talnode C production, progressing debt funding approval as part of securing Project financing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results